Concepedia

Author

Mark Klinger

Adaptive Biotechnologies (United States)

Also Known As

Klinger, Mark, M Klinger, M. Klinger, Mark B Klinger, Mark Klinger, Mark B. Klinger

62

Publications

4.2K

Citations

26

H-Index

48

Concepts

All Affiliations

Adaptive Biotechnologies (United States)University of California, San FranciscoUniversity of WashingtonNational Institutes of HealthInstitute for Systems Biology
MK

About

Mark Klinger is an author at Adaptive Biotechnologies (United States) specializing in medicine, immunology, and autoimmunity.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

14

14

1.5K

2

Cell Biology

6

6

378

3

Allergy

2

2

182

4

Public Health

1

1

27

5

Cellular Physiology

1

1

112

Mark Klinger

×

27

Publications

4.1K

Citations

25

H-Index

YearCitations

Multiple early factors anticipate post-acute COVID-19 sequelae

Yapeng Su, Dan Yuan, Daniel Chen,

Cell

2022

1.1K

Immunosequencing identifies signatures of cytomegalovirus exposure history and HLA-mediated effects on the T cell repertoire

Ryan Emerson, William S. DeWitt, Marissa Vignali,

Nature Genetics

2017

575

Improved Survival with T Cell Clonotype Stability After Anti–CTLA-4 Treatment in Cancer Patients

Edward Cha, Mark Klinger, Yafei Hou,

Science Translational Medicine

2014

376

Immune Toxicities Elicted by CTLA-4 Blockade in Cancer Patients Are Associated with Early Diversification of the T-cell Repertoire

David Y. Oh, Jason Cham, Li Zhang,

Cancer Research

2016

239

Magnitude and Dynamics of the T-Cell Response to SARS-CoV-2 Infection at Both Individual and Population Levels

Thomas M. Snyder, Rachel M. Gittelman, Mark Klinger,

2020

233

A large-scale database of T-cell receptor beta (TCRβ) sequences and binding associations from natural and synthetic exposure to SARS-CoV-2.

Sean Nolan, Marissa Vignali, Mark Klinger,

2020

164

Multiplex Identification of Antigen-Specific T Cell Receptors Using a Combination of Immune Assays and Immune Receptor Sequencing

Mark Klinger, François Pépin, Jen Wilkins,

PLoS ONE

2015

144

Immunoglobulin and T Cell Receptor Gene High-Throughput Sequencing Quantifies Minimal Residual Disease in Acute Lymphoblastic Leukemia and Predicts Post-Transplantation Relapse and Survival

Aaron C. Logan, Nikita Vashi, Malek Faham,

Biology of Blood and Marrow Transplantation

2014

136

Massive evolution of the immunoglobulin heavy chain locus in children with B precursor acute lymphoblastic leukemia

Charles Gawad, François Pépin, Victoria Carlton,

Blood

2012

122

The thrombin receptor, PAR-1, causes transformation by activation of Rho-mediated signaling pathways

Carol B. Martin, Gwendolyn M. Mahon, Mark Klinger,

Oncogene

2001

112

Page 1